Patient Preference of Apalutamide Versus Enzalutamide for Recurrent or Metastatic Hormone-sensitive Prostate Cancer: An Open-label, Randomized, Crossover Trial

Autor: Ng, Chi-Fai, Yee, Chi-Hang, Chiu, Peter Ka-Fung, Wong, Kenneth, Lam, Daisy, Yuen, Violet Wai-Fan, Lai, Pui-Tak, Teoh, Jeremy Yuen-Chun
Zdroj: In European Urology Oncology December 2024 7(6):1420-1430
Databáze: ScienceDirect
Externí odkaz: